The discontinuation of GLP-1 medications, such as Ozempic and Mounjaro, may negate the significant cardiovascular benefits they offer, highlighting the risk of heart attack and stroke in individuals who discontinue them. #Ozempic #Mounjaro #Υγεία (translated)

